首页 | 本学科首页   官方微博 | 高级检索  
     

丹参注射液合用黄芪注射液治疗冠心病心绞痛的Meta分析
引用本文:罗智浩,赖钰,蒋璐,刘云涛,严夏,王大伟. 丹参注射液合用黄芪注射液治疗冠心病心绞痛的Meta分析[J]. 世界中医药, 2021, 16(14): 2150-2156
作者姓名:罗智浩  赖钰  蒋璐  刘云涛  严夏  王大伟
作者单位:海南省中医院,海口,570000;广东省中医院,广州,510120;广州中医药大学顺德医院,佛山,528300
基金项目:广东省中医药局科研项目(20184015)
摘    要:
目的:系统评价丹参注射液合用黄芪注射液治疗冠心病心绞痛的疗效及安全性.方法:计算机检索PudMed、Co-chrane、中国学术期刊数据库(CSPD)、国家知识基础设施数据库(CNKI)、中国生物医学文献数据库(CBM)和中文科技期刊数据库(CCD)数据库,检索时间为建库至2020年3月,收集关于丹参注射液联合黄芪注射...

关 键 词:丹参注射液  黄芪注射液  冠心病  心绞痛  Meta分析
收稿时间:2019-06-14

Meta analysis of Danshen Injection and Huangqin Injection in the Treatment of Coronary Heart Disease with Angina Pectoris
LUO Zhihao,LAI Yu,JIANG Lu,LIU Yuntao,YAN Xi,WANG Dawei. Meta analysis of Danshen Injection and Huangqin Injection in the Treatment of Coronary Heart Disease with Angina Pectoris[J]. World Chinese Medicine, 2021, 16(14): 2150-2156
Authors:LUO Zhihao  LAI Yu  JIANG Lu  LIU Yuntao  YAN Xi  WANG Dawei
Affiliation:1 HaiNan Provincial Hospital of Chinese Medicine,HaiKou 570000,China; 2 Guangdong Provincial Hospital of Chinese Medicine,Guangzhou 510120,China; 3.Shunde Hospital of Guangzhou University of Chinese Medicine,Shunde 528300,China
Abstract:
To systematically evaluate the efficacy and safety of Danshen Injection and Huangshen Injection in the treatment of coronary heart disease with angina pectoris.Methods:Computer searched PudMed,Cochrane,CNKI,Wanfang,VIP and CBM database from the establishment of the library to March 2020 to collect randomized controlled trial of Danshen Injection combined with Huangqin Injection in the treatment of coronary heart disease and angina pectoris.A total of 2 reviewers extracted data according to the inclusion and exclusion criteria of the disease.The quality was evaluated according to the Jadad scale,and the RevMan 5.3 software was used for systematic evaluation.Results:A total of 2880 patients in 29 RCTs were included in the study.Meta-analysis showed that in terms of total effective rate and ECG improvement,the combined use of two injections was better than Danshen Injection alone in the treatment of coronary heart disease angina pectoris,and the difference was statistically significant(OR=4.77,95%CI [3.79 to 6.00],P<0.000 01; OR=3.96,95%CI [3.14 to 5.00],P<0.000 01); in terms of the improvement of angina pectoris,the frequency and duration of angina pectoris in the experimental group was superior to that of the control group; In terms of hemorheology,some indicators were statistically different; In terms of adverse reactions,the difference was not statistically significant(OR=1.22,95%CI [0.34 to 4.35],P=0.76).Conclusion:In the treatment of coronary heart disease angina pectoris,in the same case of conventional Western medicine treatment,the clinical efficacy,electrocardiogram improvement,angina pectoris improvement and hemorheology improvement of Danshen combined with Huangqi Injection compared with Danshen injection alone were more significant.
Keywords:Danshen Injection   Huangqin Injection   Coronary heart disease   Angina pectoris   Meta analysis
本文献已被 万方数据 等数据库收录!
点击此处可从《世界中医药》浏览原始摘要信息
点击此处可从《世界中医药》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号